Skip to content

Clinical trials

Phase 3 Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Japan Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20065
20076
20083
20101
20114
20124
20133
20141
20163
20171
20181
20211
20231
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Active, not recruiting4
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
Novartis5
Novartis Pharmaceuticals5
AstraZeneca4
Bayer3
Daiichi Sankyo Co., Ltd.3
Eli Lilly and Company3
GlaxoSmithKline2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Alcon Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension45
Essential Hypertension5
Cardiovascular Diseases4
Renal Insufficiency, Chronic2
Acute Coronary Syndrome1
Albuminuria1
Atherosclerosis1
Atrial Fibrillation1
Coronary Artery Disease1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.